(UPI) Although there has been some suggestion in studies that erectile dysfunction drugs can lower the risk for prostate cancer, a recent study showed little effect on rates of the disease, researchers report.
Roughly the same number of people using drugs for erectile dysfunction were diagnosed with prostate cancer as those not prescribed the drugs during in a study at Cedars-Sinai Medical Center.
Between 20 percent and 40 percent of men in their 60s and nearly 75 percent of men in their 70s experience erectile dysfunction, with a range of phosphodiesterase type 5 inhibitor, or PDE-5is, drugs available to treat the problem.
Some studies with mice have suggested an anticancer effect of using the drugs, though researchers involved with the study note this has been seen to a lesser extent with humans.[Click the title, above, to post a comment.]